Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
GALAPAGOS NV (GLPG) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Galapagos announces first half-year 2023 financial results",
"H1 Report 2023"
06/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
06/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
06/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
05/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
05/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
05/02/2023 6-K Quarterly results
05/02/2023 6-K Quarterly results
04/26/2023 6-K Quarterly results
04/25/2023 6-K Quarterly results
03/31/2023 6-K Quarterly results
03/27/2023 6-K Quarterly results
03/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
02/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward Looking Statements"
02/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking statements"
02/10/2023 6-K Quarterly results
02/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward Looking Statements"
01/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Corporate Presentation, titled J.P. Morgan Healthcare Conference, The information contained in slides numbered 6, 8, 9 and 18 featured in of this Report on Form 6-K, is hereby incorporated by reference into the Company's Registration Statements on Form S-8 (File Nos. 333-204567, 333-208697, 333-211834, 333-215783, 333-218160, 333-225263, 333-231765, 333-249416, 333-260500 and 333-268756)",
"Corporate Presentation, titled J.P. Morgan Healthcare Conference, The information contained in slides numbered 6, 8, 9 and 18 featured in of this Report on Form 6-K, is hereby incorporated by reference into the Company's Registration Statements on Form S-8 (File Nos. 333-204567, 333-208697, 333-211834, 333-215783, 333-218160, 333-225263, 333-231765, 333-249416, 333-260500 and 333-268756)"
01/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos receives transparency notification from FMR LLC"
01/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference Mechelen, Belgium; 3 January 2023, 22.01 CET; Galapagos NV will participate in the 41th Annual J.P. Morgan Healthcare Conference on January 9-12, 2023. Paul Stoffels 1 , CEO, will present on Monday, January 9 at 4.30 p.m. PST/7.30 p.m. ET . The presentation will be a live audio webcast and can be accessed via the following link. A replay of the webcast will be available on the Galapagos’ website at https://www.glpg.com/webcasts. About Galapagos Galapagos is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalit..."
01/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos receives transparency notification from FMR LLC Mechelen, Belgium; 23 December 2022, 22.01 CET; regulated information – Galapagos NV received a transparency notification from FMR LLC."
12/23/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos announces changes to Executive Committee"
12/13/2022 6-K Quarterly results
11/14/2022 6-K Quarterly results
11/09/2022 6-K Quarterly results
11/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results",
"Q3 Report 2022"
11/04/2022 6-K Quarterly results
10/17/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos to host its R&D Update 2022 in New York on 4 November 2022 Mechelen, Belgium; 17 October 2022, 07.30 CET; - Galapagos NV today announced that it will host its R&D Day 2022 for analysts, investors and financial press on Friday, 4 November 2022. The live event will take place at the Yale Club in New York City from 8:00 am to 10:30 am EDT . The event will feature presentations by key opinion leaders and management on the company’s strategic objectives, scientific pipeline and commercial progress. The company will also discuss its third quarter financial results, which are scheduled to be published on 3 November 2022. A live webcast of the event will be accessible through the Investor Center on the company’s website and will be available for replay following the event. Interested par..."
10/06/2022 6-K Quarterly results
09/27/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Media: Marieke Vermeersch Head of Corporate Communication +32 479 490 603 [email protected] Forward-looking statements"
08/30/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos receives transparency notification from FMR LLC"
08/24/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Galapagos to present at upcoming investor conferences Mechelen, Belgium; 24 August 2022, 22.01 CET; Galapagos NV today announced that management will participate in the following upcoming investor conferences: Citi’s 17 th Annual Biopharma Conference. September 8, 2022 in Boston Morgan Stanley 20 th Global Healthcare Conference. September 12-14, 2022 in New York Bank of America Merrill Lynch Global Healthcare Conference. September 15, 2022 in London KBC Securities Virtual Life Sciences Conference. September 16, 2022 JP Morgan CEO Call Series. September 28, 2022 Credit Suisse 31st Annual Healthcare Conference. November 8-10, 2022 in Rancho Palos Verdes, CA Bryan Garnier Virtual Conference on Cell Therapy Innovation. November 14, 2022 Jefferies 2022 Global Healthcare Conference. November 16-..."
08/19/2022 6-K Quarterly results
08/09/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy